Balancing volumes with value
When the going gets tough, the tough get going. This adage could well describe the beleaguered pharma exporters of India
Author
What ails India’s pharma exports?
It is no secret that declining pharmaceuticals exports have been worrying not just pharma honchos but the Prime Minister’s Office…
Healthcare Senate 2017 celebrates excellence and leadership in healthcare
Honours visionaries, game changers and champions with Best Hospital Pharmacy Citations and Express Healthcare Excellence Awards
A double whammy for the sector?
As expected, the August 30 meeting called by the Department of Pharmaceuticals (DoP) to discuss the Draft Pharmaceutical Policy…
India is an important, big market for us
As Merck prepares for its 350th anniversary due next year, we're 'Fit for 2018' says Dr Stefan Oschmann, Chairman of the Executive…
Draft pharma policy: Old wine in a new bottle?
The Draft Pharma Policy 2017 which was released for comments in mid-August, has an ambitious intent: to make drug pricing 'more…
Surviving serialisation
It was way back in 1963 that the US FDA finalised the first version of Good Manufacturing Practices (GMPs) for finished…
India Pharma Inc’s tryst with destiny continues
As we mark our 71st Independence Day this August 15, how far have we progressed on the medicines security front?
A wake up call for serialisation laggards
Pharma companies exporting to the US market who had their eye on the November 2017 deadline to comply with the US Drug Supply…
FDD Conclave 2017: A congregation of R&D leaders
In an endeavour to encourage research and innovation in the rapidly evolving field of formulation development and drug delivery,…